-
CDSCO's New Intelligence Cell to Check Illegal Activity in Pharma Sector
India’s central drug regulator, Central Drugs Standard Control Organisation (CDSCO), has set up a nine-member intelligence cell to track illegal acti...
2018-04-12 14:51 -
Dr. Reddy's Labs Appoints Erez Israeli as New COO
Dr. Reddy’s Laboratories Ltd. has named Mr. Erez Israeli, former President and CEO of Enzymotec, as the new Chief Operating Officer (COO) and Global ...
2018-04-12 14:51 -
EU, Australia Clear Biocon-Mylan Biosimilar Insulin Glargine
Bengaluru-based biotech firm, Biocon, said that its co-developed biosimilar insulin glargine Semglee has received marketing approval from the European...
2018-04-12 14:51 -
India: National Digital Database of Domestic Pharma Manufacturers in The Offing
India’s drug regulatory body, Central Drugs Standard Control Organisation (CDSCO), is reportedly creating a national digital database of pharmaceutic...
2018-04-12 14:51 -
India: Pharma Exports from Telangana Go up By 38%
Pharma exports, which account for 44 per cent of total merchandise exports from Telangana, are set to soar with the setting up of a new pharma city. A...
2018-04-12 14:51 -
UBM's BioLIVE Event to Introduce Global Biopharma Country Ranking
Events firm UBM’s bioprocessing and manufacturing expo, bioLIVE, which will debut this October alongside CPhI Worldwide trade fair in Madrid, is intr...
2018-04-12 14:47 -
Turkey Ramps up Pharmaceutical Expansion
The Turkish drive for a spot in the global pharmaceutical sector will involve investment incentives by the government in the form of rev...
2018-04-12 14:10 -
Clovis’ PARP Drug Gets New US Ovarian Cancer Use
The FDA has granted Clovis Oncology’s rucaparib a new use in ovarian cancer, approving the PARP inhibitor as a maintenance therapy for women with rec...
2018-04-12 14:06 -
UK Health Regulator Completes Inspection of Lupin's Goa Plant
Mumbai-based Lupin has said the UK health regulator has completed the inspection of its Goa facility without making any critical observations. In a st...
2018-04-12 14:06 -
Ionis Pharma, Astrazeneca to Advance New Drug for Nash
US-based Ionis Pharmaceuticals, the leader in antisense therapeutics, recently announced that it has licensed IONIS-AZ6-2.5-LRx, or AZD2693, to Astra...
2018-04-12 14:03
Hot News
- Global MDI/TDI Plants Enter Pe... Jul 23, 2025
- Europe Faces Unprecedented Pet... Jul 23, 2025
- BASF Launches Second Round of ... Jul 24, 2025
- Corning Acquires JA Solar’s $... Jul 30, 2025
- Sun Pharma Halts US Expansion ... Aug 03, 2025
Related Products
Related Producers
